Elevance Health (ELV) Q4 2024 Earnings Call Transcript
Good morning, and welcome to Elevance Health fourth quarter 2024 earnings call. My name is Nathan Rich, vice president of invest
Elevance Health Q4 2024 Earnings: Managed Care Continues To Impress
Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for significant upside.
Elevance Health expects to grow MA membership by at least 7% in 2025
Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's expectations despite decreasing 51% year-over-year. | Elevance Health posted $418 million in profit for the fourth quarter of 2024,
Elevance Health Inc. Profit Drops In Q4
Elevance Health Inc. (ELV) released a profit for fourth quarter that decreased from last year The company's bottom line totaled $418
Elevance Health 2024 Profits Hit $6 Billion Despite Rising Costs
Elevance Health reported nearly $6 billion in 2024 profits including $418 million in the fourth quarter as the health insurer worked to overcome rising medical expense.
Elevance Health Q4 Countdown: Smart Move to Buy or Stick With Hold?
ELV's fourth-quarter earnings are likely to have benefited from growing premiums, partially offset by higher expenses.
Elevance Health Q4 earnings miss estimates, stock rises
The company posted adjusted earnings per share of $3.84 for Q4 2024, falling short of the $3.98 consensus estimate. Revenue came in at $45 billion, slightly above the $44.9 billion analysts had projected and up 6% year-over-year.
Elevance Health: Q4 Earnings Snapshot
For the year, the company reported profit of $5.98 billion, or $25.68 per share. Revenue was reported as $175.2 billion. Elevance Health expects full-year earnings in the range of $34.15 to $34.85 per share.
Elevance Health Inc. (NYSE:ELV) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript January 23, 2025 Elevance Health Inc. beats earnings expectations. Reported EPS is $3.84, expectations were $3.8. Operator: Ladies and gentlemen, thank you for standing by,
Elevance Health Q4 Ad. EPS Miss Market, Revenues Beat; Sees Growth In FY25, Lifts Dividend; Stock Up
Elevance Health Inc. (ELV), while reporting weak fourth-quarter earnings below market estimates, on Thursday issued fiscal 2025
Elevance Earnings: Stock Rises After Results, Guidance Match Expectations
Elevance Health delivered earnings and 2025 guidance that broadly met analysts’ expectations, likely providing some relief to investors after a challenging quarter. The fourth-quarter results marked t
Healthcare Finance News1d
Elevance pulls in $418 million in Q4 profit
For the full year, that translated into $175.2 billion in revenue for Elevance (a 2.9% increase over 2023), while profit hit $5.98 billion, almost identical to its total a year ago. Operating revenue ...
Does Elevance Health (ELV) Have a Promising Long-Term Outlook?
Investment management company Vulcan Value Partners recently released its fourth-quarter 2024 investor letter. A copy of the ...